The suppression of colon cancer cell growth in nude mice by targetingβ-catenin/TCF pathway View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-11-25

AUTHORS

Ka Yin Kwong, Yiyu Zou, Chi-Ping Day, Mien-Chie Hung

ABSTRACT

The adenomatous polyposis coli (APC) or β-catenin genes are frequently mutated in colorectal cancers, leading to activation of downstream genes with β-catenin/T-cell factor (Tcf)-responsive promoters. We have developed a gene therapy approach selectively targeting colorectal cancer cells in which β-catenin/Tcf4 pathway is activated by using a recombinant adenovirus AdTOP-CMV-TK, which carries a herpes simplex virus thymidine kinase gene (HSV TK) under the control of a β-catenin/Tcf-response promoter linking to a minimum CMV promoter. AdTOP-CMV-TK and ganciclovir (GCV) treatment significantly suppressed the growth of human DLD-1 colon cancer cells in nude mice. Furthermore, no significant tumor suppression effect was observed in human hepatoma cell line SK-HEP-1, in which the β-catenin/Tcf pathway is not activated, as a control experiment. In summary, we demonstrated the selective targeting of colorectal cancers with activated β-catenin by AdTOP-CMV-TK and GCV treatment in animal models, as well as its therapeutic potential for colon cancer metastasized to liver. More... »

PAGES

8340-8346

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.onc.1206050

DOI

http://dx.doi.org/10.1038/sj.onc.1206050

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1004007292

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12447697


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colonic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytomegalovirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytoskeletal Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukin-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Nude", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Promoter Regions, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thymidine Kinase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Trans-Activators", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "beta Catenin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwong", 
        "givenName": "Ka Yin", 
        "id": "sg:person.0607767411.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607767411.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zou", 
        "givenName": "Yiyu", 
        "id": "sg:person.010162241047.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010162241047.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Day", 
        "givenName": "Chi-Ping", 
        "id": "sg:person.01272622475.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272622475.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hung", 
        "givenName": "Mien-Chie", 
        "id": "sg:person.01125127612.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125127612.53"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.onc.1202627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047778748", 
          "https://doi.org/10.1038/sj.onc.1202627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/7747", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047977858", 
          "https://doi.org/10.1038/7747"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/18884", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037595361", 
          "https://doi.org/10.1038/18884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4615-4823-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020598754", 
          "https://doi.org/10.1007/978-1-4615-4823-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2002-11-25", 
    "datePublishedReg": "2002-11-25", 
    "description": "The adenomatous polyposis coli (APC) or \u03b2-catenin genes are frequently mutated in colorectal cancers, leading to activation of downstream genes with \u03b2-catenin/T-cell factor (Tcf)-responsive promoters. We have developed a gene therapy approach selectively targeting colorectal cancer cells in which \u03b2-catenin/Tcf4 pathway is activated by using a recombinant adenovirus AdTOP-CMV-TK, which carries a herpes simplex virus thymidine kinase gene (HSV TK) under the control of a \u03b2-catenin/Tcf-response promoter linking to a minimum CMV promoter. AdTOP-CMV-TK and ganciclovir (GCV) treatment significantly suppressed the growth of human DLD-1 colon cancer cells in nude mice. Furthermore, no significant tumor suppression effect was observed in human hepatoma cell line SK-HEP-1, in which the \u03b2-catenin/Tcf pathway is not activated, as a control experiment. In summary, we demonstrated the selective targeting of colorectal cancers with activated \u03b2-catenin by AdTOP-CMV-TK and GCV treatment in animal models, as well as its therapeutic potential for colon cancer metastasized to liver.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.onc.1206050", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7138984", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "54", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "colorectal cancer", 
      "nude mice", 
      "\u03b2-catenin/TCF4 pathway", 
      "human hepatoma cell line SK-HEP-1", 
      "cancer cells", 
      "\u03b2-catenin", 
      "adenomatous polyposis coli", 
      "colorectal cancer cells", 
      "colon cancer cell growth", 
      "cancer cell growth", 
      "\u03b2-catenin/T-cell factor", 
      "significant tumor suppression effect", 
      "tumor suppression effect", 
      "human DLD-1 colon cancer cells", 
      "TCF pathway", 
      "T-cell factor", 
      "SK-Hep-1", 
      "herpes simplex virus thymidine kinase gene", 
      "simplex virus thymidine kinase gene", 
      "ganciclovir treatment", 
      "colon cancer cells", 
      "GCV treatment", 
      "animal models", 
      "gene therapy approaches", 
      "virus thymidine kinase gene", 
      "colon cancer", 
      "activated \u03b2-catenin", 
      "therapeutic potential", 
      "\u03b2-catenin gene", 
      "DLD-1 colon cancer cells", 
      "cancer", 
      "therapy approaches", 
      "selective targeting", 
      "polyposis coli", 
      "mice", 
      "thymidine kinase gene", 
      "CMV promoter", 
      "cell growth", 
      "treatment", 
      "pathway", 
      "cells", 
      "downstream genes", 
      "responsive promoter", 
      "liver", 
      "genes", 
      "kinase gene", 
      "activation", 
      "TK", 
      "promoter", 
      "targeting", 
      "suppression", 
      "suppression effect", 
      "factors", 
      "control experiments", 
      "control", 
      "summary", 
      "effect", 
      "growth", 
      "coli", 
      "potential", 
      "model", 
      "approach", 
      "experiments"
    ], 
    "name": "The suppression of colon cancer cell growth in nude mice by targeting\u03b2-catenin/TCF pathway", 
    "pagination": "8340-8346", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1004007292"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.onc.1206050"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12447697"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.onc.1206050", 
      "https://app.dimensions.ai/details/publication/pub.1004007292"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_361.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.onc.1206050"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206050'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206050'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206050'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206050'


 

This table displays all metadata directly associated to this object as RDF triples.

219 TRIPLES      21 PREDICATES      106 URIs      94 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.onc.1206050 schema:about N2641687ee1c542298364630dd9db7ab5
2 N525350066e534e599201da7b3cd45706
3 N6010504ed90a4089ab0d687882fe93a1
4 N707360338e4f4305bde53c2511f93539
5 N8098e41fee2a4d2c9c5ed542fe138500
6 N856a6c07218047fc81b27852d482b169
7 N8bd4834e80b343a1bace910f7d51a9cc
8 Na66507dddb9541bcbc5ec48013ee8bcd
9 Nad1796f8c4674f19ab1fe4581c852ced
10 Nd8593e335df24f4bbc8f98036c98268d
11 Ne2b0fc0f6bca41c3888cf1d6754e78a7
12 Nea3ea157c30b4755a17deec3c0ac79f2
13 Neb67d75ef50a4b448cfa221d6eeb389e
14 Nf3f4284ba05e4affb1bfb1632827261b
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N8f637915d105495aa9ddbd414115cef9
18 schema:citation sg:pub.10.1007/978-1-4615-4823-2
19 sg:pub.10.1038/18884
20 sg:pub.10.1038/7747
21 sg:pub.10.1038/sj.onc.1202627
22 schema:datePublished 2002-11-25
23 schema:datePublishedReg 2002-11-25
24 schema:description The adenomatous polyposis coli (APC) or β-catenin genes are frequently mutated in colorectal cancers, leading to activation of downstream genes with β-catenin/T-cell factor (Tcf)-responsive promoters. We have developed a gene therapy approach selectively targeting colorectal cancer cells in which β-catenin/Tcf4 pathway is activated by using a recombinant adenovirus AdTOP-CMV-TK, which carries a herpes simplex virus thymidine kinase gene (HSV TK) under the control of a β-catenin/Tcf-response promoter linking to a minimum CMV promoter. AdTOP-CMV-TK and ganciclovir (GCV) treatment significantly suppressed the growth of human DLD-1 colon cancer cells in nude mice. Furthermore, no significant tumor suppression effect was observed in human hepatoma cell line SK-HEP-1, in which the β-catenin/Tcf pathway is not activated, as a control experiment. In summary, we demonstrated the selective targeting of colorectal cancers with activated β-catenin by AdTOP-CMV-TK and GCV treatment in animal models, as well as its therapeutic potential for colon cancer metastasized to liver.
25 schema:genre article
26 schema:isAccessibleForFree false
27 schema:isPartOf N6f0968473e704ab9a3e4dbac335e87e1
28 Nc671258d2f974ae585fc5105aa873529
29 sg:journal.1097543
30 schema:keywords CMV promoter
31 DLD-1 colon cancer cells
32 GCV treatment
33 SK-Hep-1
34 T-cell factor
35 TCF pathway
36 TK
37 activated β-catenin
38 activation
39 adenomatous polyposis coli
40 animal models
41 approach
42 cancer
43 cancer cell growth
44 cancer cells
45 cell growth
46 cells
47 coli
48 colon cancer
49 colon cancer cell growth
50 colon cancer cells
51 colorectal cancer
52 colorectal cancer cells
53 control
54 control experiments
55 downstream genes
56 effect
57 experiments
58 factors
59 ganciclovir treatment
60 gene therapy approaches
61 genes
62 growth
63 herpes simplex virus thymidine kinase gene
64 human DLD-1 colon cancer cells
65 human hepatoma cell line SK-HEP-1
66 kinase gene
67 liver
68 mice
69 model
70 nude mice
71 pathway
72 polyposis coli
73 potential
74 promoter
75 responsive promoter
76 selective targeting
77 significant tumor suppression effect
78 simplex virus thymidine kinase gene
79 summary
80 suppression
81 suppression effect
82 targeting
83 therapeutic potential
84 therapy approaches
85 thymidine kinase gene
86 treatment
87 tumor suppression effect
88 virus thymidine kinase gene
89 β-catenin
90 β-catenin gene
91 β-catenin/T-cell factor
92 β-catenin/TCF4 pathway
93 schema:name The suppression of colon cancer cell growth in nude mice by targetingβ-catenin/TCF pathway
94 schema:pagination 8340-8346
95 schema:productId N4eefeeb1ecdb4fab9ec0aafebcb1a04c
96 N957569d8988d422bbdfbbc5184246201
97 Nffc7b020a8fb4f618b9c71be4e31a313
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004007292
99 https://doi.org/10.1038/sj.onc.1206050
100 schema:sdDatePublished 2022-09-02T15:49
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher Na2d15b6b12564390a9ebfa9d96d8c831
103 schema:url https://doi.org/10.1038/sj.onc.1206050
104 sgo:license sg:explorer/license/
105 sgo:sdDataset articles
106 rdf:type schema:ScholarlyArticle
107 N15e91b8019cd4167837dc865ec42697e rdf:first sg:person.01272622475.04
108 rdf:rest N66b503f82cbb473aa951ed1f28cf02ca
109 N2641687ee1c542298364630dd9db7ab5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Trans-Activators
111 rdf:type schema:DefinedTerm
112 N4eefeeb1ecdb4fab9ec0aafebcb1a04c schema:name dimensions_id
113 schema:value pub.1004007292
114 rdf:type schema:PropertyValue
115 N525350066e534e599201da7b3cd45706 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Mice, Nude
117 rdf:type schema:DefinedTerm
118 N6010504ed90a4089ab0d687882fe93a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Interleukin-2
120 rdf:type schema:DefinedTerm
121 N66b503f82cbb473aa951ed1f28cf02ca rdf:first sg:person.01125127612.53
122 rdf:rest rdf:nil
123 N6f0968473e704ab9a3e4dbac335e87e1 schema:volumeNumber 21
124 rdf:type schema:PublicationVolume
125 N707360338e4f4305bde53c2511f93539 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name beta Catenin
127 rdf:type schema:DefinedTerm
128 N8098e41fee2a4d2c9c5ed542fe138500 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Animals
130 rdf:type schema:DefinedTerm
131 N856a6c07218047fc81b27852d482b169 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Promoter Regions, Genetic
133 rdf:type schema:DefinedTerm
134 N8bd4834e80b343a1bace910f7d51a9cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Cytoskeletal Proteins
136 rdf:type schema:DefinedTerm
137 N8f637915d105495aa9ddbd414115cef9 rdf:first sg:person.0607767411.50
138 rdf:rest N9ebfee13308746cf9a54696ee1cfa6b3
139 N957569d8988d422bbdfbbc5184246201 schema:name pubmed_id
140 schema:value 12447697
141 rdf:type schema:PropertyValue
142 N9ebfee13308746cf9a54696ee1cfa6b3 rdf:first sg:person.010162241047.35
143 rdf:rest N15e91b8019cd4167837dc865ec42697e
144 Na2d15b6b12564390a9ebfa9d96d8c831 schema:name Springer Nature - SN SciGraph project
145 rdf:type schema:Organization
146 Na66507dddb9541bcbc5ec48013ee8bcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Cell Division
148 rdf:type schema:DefinedTerm
149 Nad1796f8c4674f19ab1fe4581c852ced schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Colonic Neoplasms
151 rdf:type schema:DefinedTerm
152 Nc671258d2f974ae585fc5105aa873529 schema:issueNumber 54
153 rdf:type schema:PublicationIssue
154 Nd8593e335df24f4bbc8f98036c98268d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Mice
156 rdf:type schema:DefinedTerm
157 Ne2b0fc0f6bca41c3888cf1d6754e78a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Cytomegalovirus
159 rdf:type schema:DefinedTerm
160 Nea3ea157c30b4755a17deec3c0ac79f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Neoplasm Transplantation
162 rdf:type schema:DefinedTerm
163 Neb67d75ef50a4b448cfa221d6eeb389e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Humans
165 rdf:type schema:DefinedTerm
166 Nf3f4284ba05e4affb1bfb1632827261b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Thymidine Kinase
168 rdf:type schema:DefinedTerm
169 Nffc7b020a8fb4f618b9c71be4e31a313 schema:name doi
170 schema:value 10.1038/sj.onc.1206050
171 rdf:type schema:PropertyValue
172 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
173 schema:name Medical and Health Sciences
174 rdf:type schema:DefinedTerm
175 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
176 schema:name Oncology and Carcinogenesis
177 rdf:type schema:DefinedTerm
178 sg:grant.7138984 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1206050
179 rdf:type schema:MonetaryGrant
180 sg:journal.1097543 schema:issn 0950-9232
181 1476-5594
182 schema:name Oncogene
183 schema:publisher Springer Nature
184 rdf:type schema:Periodical
185 sg:person.010162241047.35 schema:affiliation grid-institutes:grid.240145.6
186 schema:familyName Zou
187 schema:givenName Yiyu
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010162241047.35
189 rdf:type schema:Person
190 sg:person.01125127612.53 schema:affiliation grid-institutes:grid.240145.6
191 schema:familyName Hung
192 schema:givenName Mien-Chie
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125127612.53
194 rdf:type schema:Person
195 sg:person.01272622475.04 schema:affiliation grid-institutes:grid.240145.6
196 schema:familyName Day
197 schema:givenName Chi-Ping
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272622475.04
199 rdf:type schema:Person
200 sg:person.0607767411.50 schema:affiliation grid-institutes:grid.240145.6
201 schema:familyName Kwong
202 schema:givenName Ka Yin
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607767411.50
204 rdf:type schema:Person
205 sg:pub.10.1007/978-1-4615-4823-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020598754
206 https://doi.org/10.1007/978-1-4615-4823-2
207 rdf:type schema:CreativeWork
208 sg:pub.10.1038/18884 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037595361
209 https://doi.org/10.1038/18884
210 rdf:type schema:CreativeWork
211 sg:pub.10.1038/7747 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047977858
212 https://doi.org/10.1038/7747
213 rdf:type schema:CreativeWork
214 sg:pub.10.1038/sj.onc.1202627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047778748
215 https://doi.org/10.1038/sj.onc.1202627
216 rdf:type schema:CreativeWork
217 grid-institutes:grid.240145.6 schema:alternateName Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA
218 schema:name Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 77030, Houston, Texas, TX, USA
219 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...